Performance of Inherited Risk Assessment for Predicting Prostate Cancer From Prostate Biopsy
ConditionProstate Cancer
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexMale
Age40-69
SponsorEndeavor Health
About this trial
Condition: Prostate cancer Intervention: Biopsy and inherited risk assessment
Eligibility criteria
Qualifiers
Consecutive patients undergoing prostate biopsy for detection of prostate cancer
Aged 40 to 69 years
Four ethnicity groups (Caucasian, African Americans, East Asians, Latinos)
PSA between 2.5-10 ng/mL
Disqualifiers
Previous diagnosis of prostate cancer.
Ethnicity outside the inclusion criterion (including mixed ethnicity).
Any prior PSA test result outside the range of inclusion criterion.
Trial design
Treatments tested in this trial
- Genetic Assessment
Treatment groups
1,000 Participants
are divided into 1 treatment groupSponsors and collaborators
Endeavor Health
Lead sponsor
Northwestern University
Collaborator
Johns Hopkins University
Collaborator
GoPath Diagnostics
Collaborator
Source ClinicalTrials.gov